(Reuters) – The World Health Organization on Monday was cautious about supporting the use of recovered plasma from COVID-19 patients to treat people who are ill, saying that evidence that it works remains “low quality”, even if the United States emergency authorization for such issued therapies. PHILO PHOTO: Convalescent plasma …
Read More »
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against coronavirus (COVID-19), in Cambridge, Massachusetts, USA, May 18, 2020. REUTERS / Brian Snyder (Reuters) – Drug Developer Moderna Inc (MRNA.O) on Friday said it has so far enrolled 13,194 participants in the ongoing 30,000-volunteer …
Read More »
(Reuters) – The following is a roundup of some of the latest scientific studies on the new coronavirus and efforts to find treatments and vaccines for COVID-19, the disease caused by the virus. New questions about inhibitor COVID-19 efficacy A new study raises fresh questions about the effectiveness of Gilead …
Read More »
WELLINGTON (Reuters) – New Zealand Prime Minister Jacinda Ardern on Tuesday slammed US President Donald Trump for saying her country was experiencing a ‘big rise’ in COVID-19, calling the remarks ‘patent wrong’. PHILO PHOTO: New Zealand Prime Minister Jacinda Ardern speaks at a joint press conference with Australian Prime Minister …
Read More »
Aug 17 (Reuters) – US drug developer Novavax Inc said on Monday that it is launching a mid-term study of its experimental COVID-19 vaccine in South Africa as the country experiences an increase in coronavirus cases. The Phase 2b trial of NVX-CoV2373 will be performed on approximately 2,665 healthy adults …
Read More »